A detailed history of Suvretta Capital Management, LLC transactions in Sutro Biopharma, Inc. stock. As of the latest transaction made, Suvretta Capital Management, LLC holds 7,187,495 shares of STRO stock, worth $19.2 Million. This represents 0.98% of its overall portfolio holdings.

Number of Shares
7,187,495
Previous 7,708,690 6.76%
Holding current value
$19.2 Million
Previous $22.6 Million 10.1%
% of portfolio
0.98%
Previous 0.94%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$2.88 - $5.01 $1.5 Million - $2.61 Million
-521,195 Reduced 6.76%
7,187,495 $24.9 Million
Q2 2024

Aug 14, 2024

BUY
$2.92 - $5.33 $5.64 Million - $10.3 Million
1,930,502 Added 33.41%
7,708,690 $22.6 Million
Q4 2023

Feb 14, 2024

SELL
$2.07 - $4.54 $218,395 - $478,992
-105,505 Reduced 1.79%
5,778,188 $24.8 Million
Q2 2023

Aug 14, 2023

BUY
$4.25 - $5.88 $827,079 - $1.14 Million
194,607 Added 3.42%
5,883,693 $27.4 Million
Q1 2023

May 15, 2023

BUY
$4.48 - $8.45 $555,461 - $1.05 Million
123,987 Added 2.23%
5,689,086 $26.3 Million
Q4 2022

Feb 14, 2023

BUY
$5.41 - $8.08 $2.95 Million - $4.4 Million
545,099 Added 10.86%
5,565,099 $45 Million
Q3 2022

Nov 14, 2022

BUY
$5.17 - $7.11 $1.94 Million - $2.67 Million
375,000 Added 8.07%
5,020,000 $27.9 Million
Q2 2022

Aug 15, 2022

BUY
$3.41 - $8.95 $3.11 Million - $8.17 Million
912,600 Added 24.45%
4,645,000 $24.2 Million
Q1 2022

May 16, 2022

BUY
$7.78 - $15.31 $10.1 Million - $19.8 Million
1,294,605 Added 53.11%
3,732,400 $30.7 Million
Q4 2021

Feb 14, 2022

BUY
$14.25 - $23.53 $2.91 Million - $4.8 Million
204,100 Added 9.14%
2,437,795 $36.3 Million
Q3 2021

Nov 15, 2021

BUY
$16.88 - $22.38 $8.75 Million - $11.6 Million
518,314 Added 30.22%
2,233,695 $42.2 Million
Q2 2021

Aug 16, 2021

BUY
$18.03 - $23.82 $7.76 Million - $10.3 Million
430,405 Added 33.5%
1,715,381 $31.9 Million
Q1 2021

May 17, 2021

BUY
$20.29 - $27.54 $5.06 Million - $6.87 Million
249,567 Added 24.1%
1,284,976 $29.2 Million
Q4 2020

Feb 16, 2021

SELL
$10.16 - $23.98 $1.37 Million - $3.23 Million
-134,757 Reduced 11.52%
1,035,409 $22.5 Million
Q3 2020

Nov 16, 2020

BUY
$7.44 - $13.15 $1.99 Million - $3.52 Million
267,366 Added 29.62%
1,170,166 $11.8 Million
Q2 2020

Aug 14, 2020

BUY
$7.24 - $11.05 $5.95 Million - $9.08 Million
821,800 Added 1014.57%
902,800 $7.01 Million
Q1 2020

May 15, 2020

BUY
$6.19 - $12.16 $501,390 - $984,960
81,000 New
81,000 $826,000

Others Institutions Holding STRO

About SUTRO BIOPHARMA, INC.


  • Ticker STRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,161,500
  • Market Cap $139M
  • Description
  • Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...
More about STRO
Track This Portfolio

Track Suvretta Capital Management, LLC Portfolio

Follow Suvretta Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Suvretta Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Suvretta Capital Management, LLC with notifications on news.